Top Markets
#1 MowCat MowCat +26.72%
#2 Versatize Coin Versatize Coin +16.67%
#3 Pons Pons +10.96%
#4 Nesa Nesa +9.98%
#5 QuantixAI QuantixAI +9.67%
#6 StonkBroker StonkBroker +9.58%
#7 Wrapped NXM Wrapped NXM +9.56%
#8 Siren Siren +8.25%
#9 OriginTrail OriginTrail +7.98%
#10 Collector Crypt Collector Crypt +7.79%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
SynAct Pharma AB SynAct Pharma AB

SynAct Pharma AB

SYNACT
Rangering i aksjer #20988
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Örebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
Aksjekurs
$2.22
Sist synkronisert: 2026-08-21
Markedsverdi
$117.70M
Endring (1 dag)
2.69%
Endring (1 år)
17.26%
Land
SE
Handel SynAct Pharma AB (SYNACT)

Kategori

Healthcare
Inntekter for SynAct Pharma AB (SYNACT)
Inntekter i 2026 TTM: 0
Ifølge SynAct Pharma AB sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for SynAct Pharma AB fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH